EORTC Quality of Life Group (QLG) shared SISAQOL’s post on X, adding:
“SISAQOL is a strong example of what public–private collaboration can achieve: international stakeholders working together to improve use of quality of life data in cancer clinical trials.
EORTC Quality of Life Group is proud to be part of this initiative.”
Quoting SISAQOL’s post:
“New article from Innovative Health Initiative highlighting the work of SISAQOL on making quality of life measures in cancer clinical trials more meaningful and comparable.
A key step towards better use of PROs in research and decision‑making.”
Other articles about EORTC on OncoDaily.